SCHEMBL6452492

SCHEMBL6452492

CC(C)(C)[Si](C)(C)OCc1cnc(Nc2cccc([N+](=O)[O-])c2)nc1NCCCNC(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 4/20 0.45
BRD4 O60885 1/20 0.43
SIRT5 Q9NXA8 6/20 0.42
TLR8 Q9NR97 1/20 0.42
CDK2 P24941 4/20 0.40
CCNA2 P20248 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
CCNT1 O60563 3/20 0.40
CDK9 P50750 3/20 0.40
CDK1 P06493 2/20 0.40
CCNB1 P14635 2/20 0.40
CFTR P13569 1/20 0.40
CCNE1 P24864 2/20 0.40
CCNE2 O96020 1/20 0.40
PDPK1 O15530 1/20 0.39
STK17A Q9UEE5 1/20 0.39
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
CDK7 P50613 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3865006 0.87 TBK1 (0.49) TBK1SIRT5CDK2PDPK1
SCHEMBL3864671 0.87 TBK1 (0.38) TBK1BRD4SIRT5TLR8CDK2
SCHEMBL3864678 0.87 TBK1 (0.38) TBK1BRD4SIRT5TLR8CDK2
SCHEMBL3865668 0.86 TLR8 (0.49) TBK1BRD4SIRT5TLR8CDK2
SCHEMBL3865654 0.86 TLR8 (0.49) TBK1BRD4SIRT5TLR8CDK2
SCHEMBL3874672 0.84 TBK1 (0.46) TBK1SIRT5CDK2PDPK1STK17A
SCHEMBL13897705 0.79 SIRT5 (0.46) TBK1SIRT5
SCHEMBL13897419 0.78 TBK1 (0.45) TBK1SIRT5TLR8CDK2CCNA2
SCHEMBL12106416 0.75 PDPK1 (0.55) TBK1SIRT5CDK2PDPK1STK17A
SCHEMBL3871309 0.75 TBK1 (0.38) TBK1SIRT5CDK2PDPK1STK17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565446-A1 CHK-, PDK- AND AKT-INHIBITORY PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 2005-08-24 EP disclosed
WO-2004048343-A1 CHK-, PDK- AND AKT-INHIBITORY PYRIMIDINES, THEIR PRODUCTION AND USE AS PHARMACEUTICAL AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-06-10 WO disclosed